Status:
NOT_YET_RECRUITING
Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa
Lead Sponsor:
Geisinger Clinic
Conditions:
Hidradenitis Suppurativa (HS)
Eligibility:
All Genders
12-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).
Eligibility Criteria
Inclusion
- Geisinger male or female patients with a diagnosis of hidradenitis suppurativa (all stages of disease)
- 12-75 years of age
- Not on concurrent systemic therapy (e.g., antibiotics, biologic therapies)
- Must have not used systemic therapies within 2 weeks of enrollment in study
- Able and willing to provide consent
Exclusion
- Patients who cannot tolerate laser therapy
- Patients who cannot wear protective eyewear
- Patients who are pregnant
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06960447
Start Date
January 1 2026
End Date
July 1 2027
Last Update
December 12 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.